|
|||||
|
|
New antiangiogenic agents for renal cell carcinoma: Bevacizumab |
|
| Authors: | Ronald M. Bukowski |
| Affiliation: | Experimental Therapeutics Program, Cleveland Clinic Cancer Center, S33, 9500 Euclid Avenue, Cleveland, OH 441195, USA. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ | |